All Pharma News
Obsidian Appoints Jeffrey Trigilio As CFO

Obsidian Appoints Jeffrey Trigilio As CFO
BUSINESSWIRE
15 Apr 2024
Share Share
Obsidian Therapeutics Shares Study Data on OBX-115

Obsidian Therapeutics Shares Study Data on OBX-115
BUSINESSWIRE
09 Apr 2024
Share Share
Obsidian Therapeutics rakes in $160M for solid tumor cell therapy program

Obsidian Therapeutics rakes in $160M for solid tumor cell therapy program
Lei Lei Wu ENDPTS
03 Apr 2024
Share Share
Obsidian Therapeutics Announces Clinical & Preclinical Presentations

Obsidian Therapeutics Announces Clinical & Preclinical Presentations
BUSINESSWIRE
05 Mar 2024
Share Share
Obsidian Announces Positive Interim Top-Line Clinical Data for OBX-115

Obsidian Announces Positive Interim Top-Line Clinical Data for OBX-115
BUSINESSWIRE
12 Dec 2023
Share Share
Obsidian Therapeutics Announces Dr. Madan Jagasia as Chief Executive Officer

Obsidian Therapeutics Announces Dr. Madan Jagasia as Chief Executive Officer
BUSINESSWIRE
23 May 2023
Share Share
Maria Fardis ends a two-year CEO hiatus; More leadership turnover at Galapagos

Maria Fardis ends a two-year CEO hiatus; More leadership turnover at Galapagos
Alex Hoffman ENDPTS
05 May 2023
Share Share
Bristol Myers inks extension to Obsidian cell therapy pact

Bristol Myers inks extension to Obsidian cell therapy pact
Nick Paul Taylor FIERCEBIOTECH
27 Oct 2022
Share Share
Obsidian Therapeutics to Present Preclinical Data from cytoTIL15 Program at AACR

Obsidian Therapeutics to Present Preclinical Data from cytoTIL15 Program at AACR
PRNEWSWIRE
11 Apr 2022
Share Share
Software for the DNA hardware: Chroma snags $125M for epigenome

Software for the DNA hardware: Chroma snags $125M for epigenome
K. LaHucik FIERCEBIOTECH
18 Nov 2021
Share Share